Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.

Clinical BioBanking
With over 20 years of providing cord blood to banks hospitals, researchers and stem clinicians with systems designed to handle stem cells with the highest level of precision, safety, and confidence.
Point-of-Care Solutions
We develop products to obtain bone marrow concentrates easily, consistently, and reliably from bone marrow aspirates at the point-of-care with minimal red blood cell contamination.
Cellular Processing
The first step in the process is often the most important. That's why we have created closed-system novel and innovative technologies aimed at advancing cell therapies to the clinic.

Recent News

Getting to Know Our Vice President of Operations – Mindy Wilke-Douglas 

Mindy Wilke-Douglas, currently the Vice President of Operations, has been with ThermoGenesis since 2008. During a company-wide restructuring, she went back to the academic field, but eagerly accepted the opportunity to return when it became available. That’s how much she believes in the mission of the company and in the passion and work ethic that … Continued

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

Conference Call to be Held on May 13, 2021 RANCHO CORDOVA, Calif., May 6, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 … Continued

35 Years of ThermoGenesis: A Timeline of Events

Throughout our 35-year history, ThermoGenesis Holdings, Inc. has undergone a variety of changes. However, through it all, we’ve never strayed from the heart of our mission which is to provide the world with quality automated cell processing technologies and solutions. 35 years ago, Halley’s Comet last visited the Milky Way, Oprah Winfrey debuted her national … Continued

Making Life-Saving Therapies Accessible: An Interview With Our CEO

Innovation begins with curiosity – a desire to learn all that there is to know about a topic and then apply that knowledge for the benefit of others. Dr. Chris Xu, the CEO of ThermoGenesis Holdings Inc., is someone whose life-long curiosity has led to a mission of making life-saving therapies accessible to patients around … Continued

Immunotherapies Used to Treat Cancer

Cancer is the second leading cause of death in the United States behind heart disease according to the CDC. There are many kinds, but what they all have in common is that they start because of out-of-control growth of abnormal cells. For decades, scientists and medical professionals have researched this disease, and while a cure … Continued

Click below and be the first to hear about the latest news, breakthroughs, and products with the ThermoGenesis newsletter delivered directly to your inbox.
How may we help?